Performance analysis of Vanda Pharmaceuticals (VNDA)
Annual Return
Over the past 3 years, VNDA has had an average annual return of -6.62%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, VNDA has had an average annual return of -22.83%, underperforming the benchmark SPY, which returned +12.55% annual.
Over the past 10 years, VNDA has had an average annual return of -7.19%, underperforming the benchmark SPY, which returned +14.95% annual.
Since Apr 12, 2006, VNDA has had an average annual return of -2.91%, underperforming the benchmark SPY, which returned +11.03% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -39.68% | +84.16% | +13.49% | -42.89% | -52.90% | +19.41% | -19.93% | -37.20% | +71.91% | -4.70% | +71.31% | -34.98% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||
| +15.39% | +235.43% | -22.27% | -49.69% | -15.91% | +2,147.97% | -92.73% | -72.09% | +154.65% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -14.52% | +18.18% | -22.46% | +2.76% | -9.16% | -5.12% | -13.07% | -39.68% | |||||
| 2025 | -7.92% | +7.92% | -3.56% | -1.75% | -3.78% | +8.77% | -9.74% | +11.02% | +5.51% | -12.82% | +23.21% | +64.57% | +84.16% |
| 2024 | -14.70% | +24.17% | -8.06% | +15.80% | +7.36% | +10.57% | +3.36% | -9.41% | -11.34% | -0.85% | +10.74% | -6.99% | +13.49% |
| 2023 | +3.93% | -16.15% | +5.43% | -9.57% | -3.09% | +10.75% | -12.29% | -10.20% | -16.77% | +1.39% | -15.07% | +13.45% | -42.89% |
| 2022 | -3.38% | -25.06% | -0.44% | -12.29% | -0.91% | +10.88% | -1.10% | -1.85% | -6.61% | +5.97% | +4.21% | -32.27% | -52.90% |
| 2021 | +9.14% | +30.06% | -19.46% | +10.52% | +6.57% | +21.59% | -24.18% | +2.64% | +2.39% | -0.12% | -5.37% | -3.15% | +19.41% |
| 2020 | -22.30% | -13.48% | -6.08% | +11.01% | +1.91% | -2.39% | -11.89% | +2.08% | -6.12% | +10.66% | +14.23% | +7.61% | -19.93% |
| 2019 | +3.83% | -25.40% | -9.09% | -11.46% | -9.89% | -4.02% | -11.64% | +13.17% | -5.75% | +1.73% | +23.83% | -1.92% | -37.20% |
| 2018 | +4.28% | +18.93% | -10.61% | -17.21% | +26.17% | +8.24% | +9.45% | -7.31% | +18.76% | -17.34% | +32% | +4.35% | +71.91% |
| 2017 | -11.28% | +0.70% | -1.75% | +8.93% | -9.83% | +18.54% | -4.60% | +10.61% | +4.07% | -12.29% | -10.51% | +8.19% | -4.70% |
Drawdown analysis of Vanda Pharmaceuticals (VNDA)
The maximum drawdown for the VNDA was -98.42%, occurring on Dec 31, 2008. This drawdown has not yet recovered.
The current VNDA drawdown is -83.20%.
Since Apr 12, 2006 VNDA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 3 times
- 10% or more: 3 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.42% | Jan 24, 2007 | 489 | Dec 31, 2008 | Ongoing | Ongoing | Ongoing |
| -29.04% | Apr 20, 2006 | 48 | Jun 28, 2006 | 79 | Oct 19, 2006 | 127 |
| -28.46% | Nov 2, 2006 | 7 | Nov 13, 2006 | 2 | Nov 15, 2006 | 9 |
| -8.75% | Dec 11, 2006 | 7 | Dec 20, 2006 | 13 | Jan 11, 2007 | 20 |
| -7.22% | Nov 20, 2006 | 3 | Nov 24, 2006 | 6 | Dec 4, 2006 | 9 |
| -5.71% | Nov 15, 2006 | 1 | Nov 16, 2006 | 2 | Nov 20, 2006 | 3 |
| -3.97% | Oct 27, 2006 | 3 | Nov 1, 2006 | 1 | Nov 2, 2006 | 4 |
| -2.37% | Dec 7, 2006 | 1 | Dec 8, 2006 | 1 | Dec 11, 2006 | 2 |
| -2.20% | Oct 24, 2006 | 1 | Oct 25, 2006 | 2 | Oct 27, 2006 | 3 |
| -1.10% | Jan 11, 2007 | 1 | Jan 12, 2007 | 2 | Jan 17, 2007 | 3 |
| -0.58% | Jan 17, 2007 | 1 | Jan 18, 2007 | 1 | Jan 19, 2007 | 2 |
| -0.33% | Dec 4, 2006 | 1 | Dec 5, 2006 | 1 | Dec 6, 2006 | 2 |
| -0.03% | Jan 19, 2007 | 1 | Jan 22, 2007 | 1 | Jan 23, 2007 | 2 |